BDBM510905 6-(2-hydroxy-2- methylpropoxy)-N- [(aR)-6-({6- carbamoylthieno[3,2- b]pyridin-5- yl}oxy)spiro[3.3] heptan-2- yl]pyrazolo[1,5- a]pyridine-3- carboxamide::US11078197, Example 84::US11673886, Example 84

SMILES CC(C)(O)COc1ccc2c(cnn2c1)C(=O)N[C@H]1C[C@]2(C1)C[C@@H](C2)Oc1nc2ccsc2cc1C(N)=O

InChI Key InChIKey=OHPNCZVENDNXRB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 510905   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM510905(6-(2-hydroxy-2- methylpropoxy)-N- [(aR)-6-({6- car...)
Affinity DataIC50: 2.20E+3nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2022
Entry Details
Go to US Patent

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM510905(6-(2-hydroxy-2- methylpropoxy)-N- [(aR)-6-({6- car...)
Affinity DataIC50: 2.20nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2023
Entry Details
Go to US Patent